- Corporate
- For Print
- July 11, 2023
<Changes of Corporate Officers, effective July 10, 2023>
*You can scroll to the left or right here
| New Responsibility | Current Responsibility | Name |
|---|---|---|
| Senior Vice President
Acting President, Americas Region Acting Chairman & CEO, Eisai Inc. |
Senior Vice President
Chief Financial Officer Chief IR Officer |
Tatsuyuki Yasuno |
| Senior Vice President
Chief Government Relations Officer Chief IR Officer Global Value & Access General Affairs, Environmental and Safety Affairs Japan Subsidiaries |
Senior Vice President
Chief Government Relations Officer Global Value & Access General Affairs, Environmental and Safety Affairs Japan Subsidiaries |
Masatomi Akana |
| Senior Vice President
Chief Strategy & Planning Officer Chief Ecosystem Officer Acting Global Alzheimer's Disease Officer |
Senior Vice President
Chief Strategy & Planning Officer Chief Ecosystem Officer |
Keisuke Naito |
| Vice President
Head of Corporate Planning and Business Development HQs |
Senior Group Officer
Head of Corporate Planning and Business Development HQs |
Toshitaka Asano |
| Vice President
Chief Financial Officer Head of Corporate Finance and Accounting HQs |
Group Officer
Head of Corporate Finance and Accounting HQs |
Mitsuru Shomon |
* Ivan Cheung, currently Senior Vice President, Global Alzheimer's Disease Officer, President, Americas Region and Chairman & CEO, Eisai Inc., will retire as of July 31, 2023.
Media Inquiries:
Public Relations Department,
Eisai Co., Ltd.
+81-(0)3-3817-5120
Our news releases are intended to disclose corporate information and are not intended for the promotion or advertising of prescription pharmaceuticals or investigational products, nor are they intended to provide medical advice.
Please note that the information contained in news releases is current as of the date of publication.